Variable clinical expression in patients with mosaicism for KCNQ2 mutations

Area of Science:

• Neurogenetics
• Epilepsy Research
• Molecular Biology

Background:

• KCNQ2 gene mutations are linked to a spectrum of epileptic phenotypes, from benign familial neonatal epilepsy (BFNE) to early infantile epileptic encephalopathy type 7 (EIEE7).
• Disease severity typically correlates with mutation type, though significant intra- and interfamilial variability exists.
• BFNE mutations are often inherited, while EIEE7 mutations are typically de novo.

Purpose of the Study:

• To investigate KCNQ2 mutation carriers who have children with severe epileptic phenotypes.
• To determine the presence and implications of mosaicism in KCNQ2 mutation carriers.
• To assess the impact of these findings on genetic counseling and understanding of KCNQ2-related neurological development.

Main Methods:

• Identification of KCNQ2 mutation carriers with affected offspring.
• Molecular analysis to detect KCNQ2 mutations in identified carriers.
• Correlation of genetic findings with clinical phenotypes and neurological development.

Main Results:

• Identified KCNQ2 mutation carriers whose children presented with severe epileptic phenotypes.
• Confirmed that these carriers were mosaic for the KCNQ2 mutation (presence of the mutation in a subset of cells).
• Demonstrated that individuals with somatic mosaicism for KCNQ2 mutations can exhibit normal neurological development.

Conclusions:

• Somatic mosaicism for KCNQ2 mutations is a significant factor in the inheritance of severe epilepsy.
• The presence of mosaicism can explain the transmission of severe KCNQ2-related epilepsy from phenotypically normal or mildly affected parents.
• These findings necessitate revised genetic counseling strategies for families with KCNQ2-related epilepsies, highlighting the possibility of normal development despite mosaicism.